Cargando…
FERTILITY PRESERVATION IN YOUNG WOMEN WITH EARLY-STAGE BREAST CANCER
Although breast cancer (BC) occurs more often in older women, it is the most commonly diagnosed malignancy in women of childbearing age. Owing to the overall advancement of modern medicine and the growing global trend of delaying childbirth until later age, we find ever more younger women diagnosed...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sestre Milosrdnice University Hospital and Institute of Clinical Medical Research, Vinogradska cesta c. 29 Zagreb
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6629203/ https://www.ncbi.nlm.nih.gov/pubmed/31363337 http://dx.doi.org/10.20471/acc.2019.58.01.19 |
_version_ | 1783435068050505728 |
---|---|
author | Vuković, Petra Kasum, Miro Raguž, Jelena Lonjak, Nikolina Bilić Knežević, Sara Orešković, Ivana Beketić Orešković, Lidija Čehić, Ermin |
author_facet | Vuković, Petra Kasum, Miro Raguž, Jelena Lonjak, Nikolina Bilić Knežević, Sara Orešković, Ivana Beketić Orešković, Lidija Čehić, Ermin |
author_sort | Vuković, Petra |
collection | PubMed |
description | Although breast cancer (BC) occurs more often in older women, it is the most commonly diagnosed malignancy in women of childbearing age. Owing to the overall advancement of modern medicine and the growing global trend of delaying childbirth until later age, we find ever more younger women diagnosed and treated for BC who have not yet completed their family. Therefore, fertility preservation has emerged as a very important quality of life issue for young BC survivors. This paper reviews currently available options for fertility preservation in young women with early-stage BC and highlights the importance of a multidisciplinary approach to fertility preservation as a very important quality of life issue for young BC survivors. Pregnancy after BC treatment is considered not to be associated with an increased risk of BC recurrence; therefore, it should not be discouraged for those women who want to achieve pregnancy after oncologic treatment. Currently, it is recommended to delay pregnancy for at least 2 years after BC diagnosis, when the risk of recurrence is highest. However, BC patients of reproductive age should be informed about the potential negative effects of oncologic therapy on fertility, as well as on the fertility preservation options available, and if interested in fertility preservation, they should be promptly referred to a reproductive specialist. Early referral to a reproductive specialist is an important factor that increases the likelihood of successful fertility preservation. Embryo and mature oocyte cryopreservation are currently the only established fertility preservation methods but they require ovarian stimulation (OS), which delays initiation of chemotherapy for at least 2 weeks. Controlled OS does not seem to increase the risk of BC recurrence. Other fertility preservation methods (ovarian tissue cryopreservation, cryopreservation of immature oocytes and ovarian suppression with gonadotropin-releasing hormone agonists) do not require OS but are still considered to be experimental techniques for fertility preservation. |
format | Online Article Text |
id | pubmed-6629203 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Sestre Milosrdnice University Hospital and Institute of Clinical Medical Research, Vinogradska cesta c. 29 Zagreb |
record_format | MEDLINE/PubMed |
spelling | pubmed-66292032019-07-30 FERTILITY PRESERVATION IN YOUNG WOMEN WITH EARLY-STAGE BREAST CANCER Vuković, Petra Kasum, Miro Raguž, Jelena Lonjak, Nikolina Bilić Knežević, Sara Orešković, Ivana Beketić Orešković, Lidija Čehić, Ermin Acta Clin Croat Reviews Although breast cancer (BC) occurs more often in older women, it is the most commonly diagnosed malignancy in women of childbearing age. Owing to the overall advancement of modern medicine and the growing global trend of delaying childbirth until later age, we find ever more younger women diagnosed and treated for BC who have not yet completed their family. Therefore, fertility preservation has emerged as a very important quality of life issue for young BC survivors. This paper reviews currently available options for fertility preservation in young women with early-stage BC and highlights the importance of a multidisciplinary approach to fertility preservation as a very important quality of life issue for young BC survivors. Pregnancy after BC treatment is considered not to be associated with an increased risk of BC recurrence; therefore, it should not be discouraged for those women who want to achieve pregnancy after oncologic treatment. Currently, it is recommended to delay pregnancy for at least 2 years after BC diagnosis, when the risk of recurrence is highest. However, BC patients of reproductive age should be informed about the potential negative effects of oncologic therapy on fertility, as well as on the fertility preservation options available, and if interested in fertility preservation, they should be promptly referred to a reproductive specialist. Early referral to a reproductive specialist is an important factor that increases the likelihood of successful fertility preservation. Embryo and mature oocyte cryopreservation are currently the only established fertility preservation methods but they require ovarian stimulation (OS), which delays initiation of chemotherapy for at least 2 weeks. Controlled OS does not seem to increase the risk of BC recurrence. Other fertility preservation methods (ovarian tissue cryopreservation, cryopreservation of immature oocytes and ovarian suppression with gonadotropin-releasing hormone agonists) do not require OS but are still considered to be experimental techniques for fertility preservation. Sestre Milosrdnice University Hospital and Institute of Clinical Medical Research, Vinogradska cesta c. 29 Zagreb 2019-03 /pmc/articles/PMC6629203/ /pubmed/31363337 http://dx.doi.org/10.20471/acc.2019.58.01.19 Text en http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License. |
spellingShingle | Reviews Vuković, Petra Kasum, Miro Raguž, Jelena Lonjak, Nikolina Bilić Knežević, Sara Orešković, Ivana Beketić Orešković, Lidija Čehić, Ermin FERTILITY PRESERVATION IN YOUNG WOMEN WITH EARLY-STAGE BREAST CANCER |
title | FERTILITY PRESERVATION IN YOUNG WOMEN WITH EARLY-STAGE BREAST CANCER |
title_full | FERTILITY PRESERVATION IN YOUNG WOMEN WITH EARLY-STAGE BREAST CANCER |
title_fullStr | FERTILITY PRESERVATION IN YOUNG WOMEN WITH EARLY-STAGE BREAST CANCER |
title_full_unstemmed | FERTILITY PRESERVATION IN YOUNG WOMEN WITH EARLY-STAGE BREAST CANCER |
title_short | FERTILITY PRESERVATION IN YOUNG WOMEN WITH EARLY-STAGE BREAST CANCER |
title_sort | fertility preservation in young women with early-stage breast cancer |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6629203/ https://www.ncbi.nlm.nih.gov/pubmed/31363337 http://dx.doi.org/10.20471/acc.2019.58.01.19 |
work_keys_str_mv | AT vukovicpetra fertilitypreservationinyoungwomenwithearlystagebreastcancer AT kasummiro fertilitypreservationinyoungwomenwithearlystagebreastcancer AT raguzjelena fertilitypreservationinyoungwomenwithearlystagebreastcancer AT lonjaknikolina fertilitypreservationinyoungwomenwithearlystagebreastcancer AT bilicknezevicsara fertilitypreservationinyoungwomenwithearlystagebreastcancer AT oreskovicivana fertilitypreservationinyoungwomenwithearlystagebreastcancer AT beketicoreskoviclidija fertilitypreservationinyoungwomenwithearlystagebreastcancer AT cehicermin fertilitypreservationinyoungwomenwithearlystagebreastcancer |